Plantar Wart Treatment Using Adapalene Gel

• Status: Not yet recruiting
• Trial end date: 2023-02-10
• Target enrollment: 0
• Participant gender: All

Summary

This study seeks to research the efficacy of Adapalene 0.1% gel as a cost effective and low risk treatment option for plantar warts of the foot. Patients that present/diagnosed in designated clinics with plantar warts will be offered the option of being treated with regular superficial debridements of the epidermis and twice a day application of adapalene gel 0.1% under occlusion. Patients will be followed until resolution.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Jonathan M Towarnicki
• Treatments: Adapalene

Criteria

Inclusion Criteria:

• patients must be diagnosed with plantar warts

Exclusion Criteria:

• pregnant women

• previous wart treatment within the last 2 weeks